Anticardiolipin Syndrome
Links shared publicly online about this topic
Phadia's four new EliA autoimmune antibody assays receive FDA clearance
news-medical.net — “Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.” View full resource at news-medical.net
Most Recently Shared on June 25, 2010 at 10:07 am By:
Stroke News: Phadia's four new EliA autoimmune antibody assays receive FDA clearance: Today Phadia announced tha... http://twurl.nl/npwhf3
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Stroke news and research via News-Medical.Net
Advertisement
